The Economic Impact of Pharmaceutical Parallel Trade in European Union Member States: A Stakeholder Analysis

Abstract

• Direct savings accruing to statutory health insurance organisations from the conduct of parallel trade are modest both in absolute and relative terms. These savings (in € ‘000) are as follows for 2002: Norway Germany Sweden Denmark UK Netherlands € € % Total market % Total market 563 0.3% 17,730 0.8% 3,770 1.3% 3,002 2.2% 6,887 55,887 0.3% 2.8% 12,762 19,119 2.2% 3.6% Note: 1 Includes estimates for the clawback.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 86 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.